In recent years, modern research has made new progress - Shexiang Baoxin Pill promotes angiogenesis in the treatment of coronary heart disease. Angiogenesis is a compensatory mechanism and repairing method for hypoxic-ischemic injury. Therapeutic angiogenesis promotes the development of a new blood-supplying small blood vessel by ischemic myocardium and establishes an effective collateral circulation. To achieve the purpose of restoring blood supply to ischemic myocardium and improving the symptoms and prognosis of patients. Shexiang Baoxin Pill is a Chinese patent medicine that has been proven to promote therapeutic angiogenesis.
At present, the research on drug-promoting therapeutic angiogenesis mainly focuses on the extracts of Shexiang Baoxin Pills and Rhodiola, Angelica and Sanqi. In the animal model, it was found that Shexiang Baoxin Pill has a significant effect on promoting therapeutic angiogenesis. It has also been found to improve the blood supply of ischemic myocardium by evaluating the myocardial influence of the patient.
Shexiang Baoxin Pill has obvious pro-angiogenic activity, can promote microvascular endothelial cell proliferation and form luminal structure, increase myocardial vascular surface density, and its mechanism of angiogenesis can be related to endothelial cell expression and release of angiogenic growth factor. . Studies have confirmed that long-term use of Shexiang Baoxin Pill can promote angiogenesis in ischemic myocardium, thereby improving myocardial ischemia and fundamentally treating coronary heart disease.
From the current research and application, the method of promoting the treatment of angiogenesis by Shexiang Baoxin Pill is safe, effective and convenient, and the research on the objective evaluation of the therapeutic effect of Shexiang Baoxin Pill is gradually increasing.
At the beginning of 2006, the drug won the first China Association of Integrative Medicine Science and Technology Award for angiogenesis, and published several papers in authoritative journals such as LifeScience. In the clinical application of modern coronary heart disease treatment, Shexiang Baoxin Pill has a unique position. It is not only a proprietary Chinese medicine that promotes the angiogenesis of ischemic myocardium, but also a proprietary Chinese medicine for relieving chest tightness and chest pain. Widely recognized by the industry and the majority of patients, this is considered to be an important reason why Muxiang Baoxin Pill can obtain approval for national confidential products.
Medical Coveralls,Best Lab Coats For Chemistry,Surgical Disposable Gown,Non-Woven Protective Clothing
Wuxi Kanghe Medical Consulting Co., Ltd. , https://www.jskanghe.com